Among them, the thiazolidinediones, acting on the nuclear transcription factor peroxisome proliferator-activated receptor gamma (PPAR)-γ and thus true insulin sensitizers drugs, have demonstrated the best efficacy, improving liver histology in NASH independently from the presence of diabetes [232,233]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.